SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-03-000038
Filing Date
2003-11-12
Accepted
2003-11-12 12:37:02
Documents
8
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 09/30/2003 10-Q ligand090310q.htm 10-Q 357363
3 EXHIBIT 10.261 ex10-261.txt EX-10 30269
4 EXHIBIT 10.262 ex10-262.txt EX-10 30275
5 EXHIBIT 10.263 ex10-263.txt EX-10 19032
6 EXHIBIT 99.1 ex99-1.txt EX-99 3110
7 EXHIBIT 99.2 ex99-2.txt EX-99 3096
8 EXHIBIT 99.3 ex99-3.txt EX-99 1492
9 EXHIBIT 99.4 ex99-4.txt EX-99 1474
  Complete submission text file 0000886163-03-000038.txt   448386
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 03992384
SIC: 2834 Pharmaceutical Preparations